SK133297A3 - Imidazo[1,2-a]pyridine derivatives, pharmaceutical composition containing same and their use - Google Patents

Imidazo[1,2-a]pyridine derivatives, pharmaceutical composition containing same and their use Download PDF

Info

Publication number
SK133297A3
SK133297A3 SK1332-97A SK133297A SK133297A3 SK 133297 A3 SK133297 A3 SK 133297A3 SK 133297 A SK133297 A SK 133297A SK 133297 A3 SK133297 A3 SK 133297A3
Authority
SK
Slovakia
Prior art keywords
formula
compound
alkyl
methyl
pharmaceutically acceptable
Prior art date
Application number
SK1332-97A
Other languages
English (en)
Slovak (sk)
Inventor
Paul J Beswick
Ian B Campbell
Alan Naylor
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9506965.4A external-priority patent/GB9506965D0/en
Priority claimed from GBGB9512099.4A external-priority patent/GB9512099D0/en
Priority claimed from GBGB9516117.0A external-priority patent/GB9516117D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SK133297A3 publication Critical patent/SK133297A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
SK1332-97A 1995-04-04 1996-04-02 Imidazo[1,2-a]pyridine derivatives, pharmaceutical composition containing same and their use SK133297A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9506965.4A GB9506965D0 (en) 1995-04-04 1995-04-04 Chemical compounds
GBGB9512099.4A GB9512099D0 (en) 1995-06-14 1995-06-14 Chemical compounds
GBGB9516117.0A GB9516117D0 (en) 1995-08-05 1995-08-05 Chemical compounds
PCT/EP1996/001438 WO1996031509A1 (en) 1995-04-04 1996-04-02 IMIDAZO[1,2-a]PYRIDINE DERIVATIVES

Publications (1)

Publication Number Publication Date
SK133297A3 true SK133297A3 (en) 1998-07-08

Family

ID=27267657

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1332-97A SK133297A3 (en) 1995-04-04 1996-04-02 Imidazo[1,2-a]pyridine derivatives, pharmaceutical composition containing same and their use

Country Status (17)

Country Link
EP (1) EP0819127A1 (xx)
JP (1) JPH11501049A (xx)
KR (1) KR19980703559A (xx)
CN (1) CN1186492A (xx)
AU (1) AU5276696A (xx)
BG (1) BG101934A (xx)
CA (1) CA2216809A1 (xx)
CZ (1) CZ313397A3 (xx)
EA (1) EA199700209A1 (xx)
HU (1) HUP9801602A3 (xx)
IS (1) IS4570A (xx)
NO (1) NO974595L (xx)
NZ (1) NZ304886A (xx)
PL (1) PL322623A1 (xx)
SK (1) SK133297A3 (xx)
TR (1) TR199701105T1 (xx)
WO (1) WO1996031509A1 (xx)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764292B1 (fr) * 1997-06-10 2000-12-29 Innothera Lab Sa Utilisation de derives de tetracycles dicetoniques, nouveaux composes obtenus et leur application en therapeutique
US6525053B1 (en) 1997-08-22 2003-02-25 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6307047B1 (en) 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
CN1155600C (zh) 1997-09-05 2004-06-30 葛兰素集团有限公司 2,3-二芳基吡唑并[1,5-b]哒嗪衍生物,其制备方法和用作环氧酶2抑制剂
FR2770131A1 (fr) * 1997-10-27 1999-04-30 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
FR2771005B1 (fr) * 1997-11-18 2002-06-07 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
GB9810920D0 (en) * 1998-05-21 1998-07-22 Merck Sharp & Dohme Therapeutic use
ES2140354B1 (es) * 1998-08-03 2000-11-01 S A L V A T Lab Sa Imidazo (1,2a) azinas sustituidas como inhibidores selectivos de la cox-2.
TW587079B (en) * 1998-09-25 2004-05-11 Almirall Prodesfarma Ag 2-phenylpyran-4-one derivatives
CA2349567A1 (en) * 1998-11-03 2000-05-11 Glaxo Group Limited Pyrazolopyridine derivatives as selective cox-2 inhibitors
WO2000052008A1 (en) * 1999-02-27 2000-09-08 Glaxo Group Limited Pyrazolopyridines
GB9930358D0 (en) * 1999-12-22 2000-02-09 Glaxo Group Ltd Process for the preparation of chemical compounds
IL150368A0 (en) 1999-12-23 2002-12-01 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use
GB0002312D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
PE20011333A1 (es) 2000-03-16 2002-01-16 Almirall Prodesfarma Ag Derivados de 2-fenilpiran-4-ona como inhibidores de ciclooxigenasa 2
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
PL359556A1 (en) 2000-07-20 2004-08-23 Lauras As Method - use of cox-2 inhibitors for preventing immunodeficiency
PE20020506A1 (es) * 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
GB0025449D0 (en) * 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
ES2245380T3 (es) 2000-12-15 2006-01-01 Glaxo Group Limited Pirazolopiridinas.
WO2002048148A2 (en) 2000-12-15 2002-06-20 Glaxo Group Limited Pyrazolopyridine derivatives
JP2004529119A (ja) 2001-03-08 2004-09-24 スミスクライン ビーチャム コーポレーション ピラゾロピリジン誘導体
JP4237497B2 (ja) 2001-03-30 2009-03-11 スミスクライン ビーチャム コーポレーション ピラゾロピリジン類、その調製方法及びその治療用化合物としての使用
MY137736A (en) 2001-04-03 2009-03-31 Pharmacia Corp Reconstitutable parenteral composition
JP4219171B2 (ja) 2001-04-10 2009-02-04 スミスクライン ビーチャム コーポレーション 抗ウイルス性ピラゾロピリジン化合物
DE60204452T2 (de) 2001-04-27 2005-12-15 Smithkline Beecham Corp. Pyrazolo[1,5a]Pyridinderivate
US6756498B2 (en) 2001-04-27 2004-06-29 Smithkline Beecham Corporation Process for the preparation of chemical compounds
US7186714B2 (en) 2001-06-21 2007-03-06 Smithkline Beecham Corporation Imidazo[1,2-α]pyridine derivatives for the prophylaxis and treatment of herpes viral infections
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
ES2262893T3 (es) 2001-10-05 2006-12-01 Smithkline Beecham Corporation Derivados de imidazo-piridina para su uso en el tratamiento de infeccion virica por herpes.
GB0124939D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124936D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124941D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124931D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124933D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124938D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124934D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
JP2005516916A (ja) 2001-12-11 2005-06-09 スミスクライン ビーチャム コーポレーション 抗ヘルペス薬としてのピラゾロ−ピリジン誘導体
DE60316913T2 (de) 2002-02-12 2008-11-20 Smithkline Beecham Corp. Nicotinamide und deren verwendung als p38 inhibitoren
US7211598B2 (en) 2002-06-28 2007-05-01 Nitromed, Inc. Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
GB0217757D0 (en) 2002-07-31 2002-09-11 Glaxo Group Ltd Novel compounds
EP1546148A1 (en) 2002-10-03 2005-06-29 SmithKline Beecham Corporation Therapeutic compounds based on pyrazolopyridine derivatives
KR20040072004A (ko) 2003-02-07 2004-08-16 삼성에스디아이 주식회사 유기 전계 발광 소자용 발광 화합물 및 그를 이용한 유기전계발광 소자
GB0308201D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
GB0308186D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
GB0308185D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
JP4354984B2 (ja) 2003-05-07 2009-10-28 オステオロジックス エイ／エス 水溶性ストロンチウム塩を用いる軟骨／骨症状の治療
GB0318814D0 (en) 2003-08-11 2003-09-10 Smithkline Beecham Corp Novel compounds
US8067464B2 (en) 2004-10-04 2011-11-29 Nitromed, Inc. Compositions and methods using apocynin compounds and nitric oxide donors
WO2007016677A2 (en) 2005-08-02 2007-02-08 Nitromed, Inc. Nitric oxide enhancing antimicrobial compounds, compositions and methods of use
AU2007243765A1 (en) 2006-03-29 2007-11-08 Nicox S.A. Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
RU2487875C2 (ru) 2006-11-06 2013-07-20 Толеро Фармасьютикалз,Инк. ПРОИЗВОДНЫЕ ИМИДАЗО [1,2-b]ПИРИДАЗИНА И ПИРАЗОЛО[1,5-a]ПИРИМИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРА ПРОТЕИНКИНАЗ
DK3409278T3 (da) 2011-07-21 2020-11-09 Sumitomo Dainippon Pharma Oncology Inc Heterocykliske proteinkinaseinhibitorer
EP3292213A1 (en) 2015-05-04 2018-03-14 Academisch Medisch Centrum Biomarkers for the detection of aspirin insensitivity
US11471456B2 (en) 2019-02-12 2022-10-18 Sumitomo Pharma Oncology, Inc. Formulations comprising heterocyclic protein kinase inhibitors
WO2022195579A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455924A (en) * 1967-02-08 1969-07-15 Upjohn Co Dianisylimidazoles

Also Published As

Publication number Publication date
IS4570A (is) 1997-09-25
NO974595L (no) 1997-12-03
KR19980703559A (ko) 1998-11-05
CZ313397A3 (cs) 1998-03-18
NO974595D0 (no) 1997-10-03
AU5276696A (en) 1996-10-23
NZ304886A (en) 1998-11-25
JPH11501049A (ja) 1999-01-26
EP0819127A1 (en) 1998-01-21
PL322623A1 (en) 1998-02-02
CN1186492A (zh) 1998-07-01
TR199701105T1 (xx) 1998-02-21
HUP9801602A3 (en) 1999-01-28
BG101934A (en) 1999-04-30
HUP9801602A2 (hu) 1998-11-30
WO1996031509A1 (en) 1996-10-10
CA2216809A1 (en) 1996-10-10
EA199700209A1 (ru) 1998-04-30
MX9707379A (es) 1997-11-29

Similar Documents

Publication Publication Date Title
SK133297A3 (en) Imidazo[1,2-a]pyridine derivatives, pharmaceutical composition containing same and their use
US6831097B2 (en) 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
CA3037728C (en) 4,6-indazole compounds and methods for ido and tdo modulation, and indications therefor
ES2216631T3 (es) Pirazolpiridinas.
ES2228127T3 (es) Derivados de pirazolopiridina como inhibidores selectivos de cox-2.
JP2017061517A (ja) キナーゼ調節のための化合物と方法、及びそのための適応
JPH09507855A (ja) ピラゾロおよびピロロピリジン類
WO2004072018A1 (ja) アミン誘導体
MX2007011110A (es) Formas de cristal de un derivado de imidazol.
WO2021055376A1 (en) Il-17a modulators and uses thereof
CZ20021802A3 (cs) Deriváty pyrimidinů
RU2697090C1 (ru) Производные тетрагидроимидазопиридина в качестве модуляторов активности tnf
JP2023545352A (ja) 結晶性ｅｄｇ－２受容体アンタゴニストおよび製造方法
US8394824B2 (en) Quinuclidine compounds having quaternary ammonium group, its preparation method and use as blocking agents of acetylcholine
JP2004532264A (ja) ピリミジン誘導体
CZ20022742A3 (cs) Pyrrolpyridazinové deriváty
MXPA97007379A (en) Derivatives of imidazo [1,2-a] pirid
HRP960425A2 (en) Chemical compounds
JP3657986B2 (ja) イミダゾ〔１，５−ａ〕インドール−３−オンのイミダゾリルアルキル誘導体およびそれらの製造法
JPS6112689A (ja) 環式アミド、その製法及び該化合物を含有する糖尿病及びガラクトース血症の合併症を治療又は予防するための製薬的組成物
JP3484115B2 (ja) 縮合ピリダジン誘導体、その製造法および用途
WO2022228509A1 (zh) 吡咯并嘧啶衍生物及其制备方法和用途
JP2001199889A (ja) 縮合ピリダジン誘導体を含有してなる点鼻用剤